MENU
SEPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Septerna (SEPN) Ownership - Who owns Septerna?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.35B
P/E Ratio
N/A
Total Cash
474.35M
Projected Growth
N/A
Total Debt
24.11M
Revenue
22.05M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.52
Total Debt/Equity
N/A
Revenue/Share
1.63 USD as % of share price
View a ticker or compare two or three
SEPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details